AILatest
FDA Push for Trial Transparency and Novo-OpenAI Deal
The FDA is advocating for greater transparency in clinical trials, aiming to enhance public trust. Additionally, Novo Nordisk has partnered with OpenAI to leverage AI in drug development.
0 upvotes
What happened
The FDA is advocating for greater transparency in clinical trials, aiming to enhance public trust.
Why it matters
Additionally, Novo Nordisk has partnered with OpenAI to leverage AI in drug development.